Estadístiques de SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia
Visites totals
| views | |
|---|---|
| SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia | 53 |
Visites totals per mes
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 3 |
| September 2024 | 6 |
| October 2024 | 0 |
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Lopez_lsa_sf3b.pdf(legacy) | 16 |
| Lopez_lsa_sf3b.pdf | 1 |
Vistes principals per país
| views | |
|---|---|
| United States | 41 |
| Spain | 5 |
| Canada | 2 |
| Germany | 2 |
| Argentina | 1 |
| United Kingdom | 1 |
| Ireland | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Mountain View | 6 |
| San Mateo | 4 |
| Barcelona | 3 |
| Cambridge | 3 |
| Tustin | 3 |
| Boardman | 2 |
| Fremont | 2 |
| Menlo Park | 2 |
| Munich | 2 |
| Ottawa | 2 |
| San Diego | 2 |
| Ann Arbor | 1 |
| Cupertino | 1 |
| Dearborn | 1 |
| Madrid | 1 |
| Oviedo | 1 |
| Rochester | 1 |
| Seattle | 1 |
| Sheffield | 1 |
| Suipacha | 1 |